ABSENCE OF HEREDITARY P53 MUTATIONS IN 10 FAMILIAL LEUKEMIA PEDIGREES

被引:44
作者
FELIX, CA
DAMICO, D
MITSUDOMI, T
NAU, MM
LI, FP
FRAUMENI, JF
COLE, DE
MCCALLA, J
REAMAN, GH
WHANGPENG, J
KNUTSEN, T
MINNA, JD
POPLACK, DG
机构
[1] NCI,PEDIAT BRANCH,BETHESDA,MD 20892
[2] NCI,NAVY MED ONCOL BRANCH,BETHESDA,MD 20892
[3] NCI,EPIDEMIOL BRANCH,BETHESDA,MD 20892
[4] NCI,MED BRANCH,BETHESDA,MD 20892
[5] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,NATL CANC INST,BOSTON,MA 02115
[6] GEORGE WASHINGTON UNIV,CHILDRENS NATL MED CTR,DIV HEMATOL ONCOL,WASHINGTON,DC 20010
[7] UNIV TEXAS,SW MED CTR,SIMMONS CANC RES CTR,DALLAS,TX 75235
关键词
ACUTE LYMPHOBLASTIC LEUKEMIA; GERMLINE MUTATION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;
D O I
10.1172/JCI115907
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Germline p53 mutations have been identified in the Li-Fraumeni syndrome but the role of such mutations in familial leukemia is not established. The p53 gene was examined by single-strand conformation polymorphism analysis of exons 4-8 in 10 families with multiple members affected with leukemia. The diagnoses included acute and chronic leukemias and Hodgkin's disease. Identified in two families were p53 mutations that were nonhereditary. These included a 2-bp deletion in exon 6 found in the lymphoblast DNA of one child whose sibling, cousin, and several adult relatives had acute leukemia. The other nonhereditary p53 mutation was a transition at codon 248 (CGG to CAG, arginine to glutamine) found in the lymphoblasts of a patient with a preleukemic syndrome and acute lymphoblastic leukemia (ALL) whose brother is a long-term survivor of ALL. Thus, p53 mutations were found to occur in two families but both were nonhereditary. Moreover, in the remaining eight families no p53 mutation was identified in the regions of p53 where most mutations have been found in other cancers. Although p53 mutations sometimes may be present, they do not appear to be a primary event responsible for hereditary susceptibility to familial leukemia. This study suggests involvement of other genes or mechanisms.
引用
收藏
页码:653 / 658
页数:6
相关论文
共 31 条
[11]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[12]   GERM-LINE AND SOMATIC P53 GENE-MUTATIONS IN MULTIFOCAL OSTEOGENIC-SARCOMA [J].
IAVARONE, A ;
MATTHAY, KK ;
STEINKIRCHNER, TM ;
ISRAEL, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4207-4209
[13]   HIGH-INCIDENCE OF LUNG, BONE, AND LYMPHOID TUMORS IN TRANSGENIC MICE OVEREXPRESSING MUTANT ALLELES OF THE P53 ONCOGENE [J].
LAVIGUEUR, A ;
MALTBY, V ;
MOCK, D ;
ROSSANT, J ;
PAWSON, T ;
BERNSTEIN, A .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (09) :3982-3991
[14]   THE P53 TUMOR SUPPRESSOR GENE [J].
LEVINE, AJ ;
MOMAND, J ;
FINLAY, CA .
NATURE, 1991, 351 (6326) :453-456
[15]  
LI FP, 1969, J NATL CANCER I, V43, P1365
[16]   GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS [J].
MALKIN, D ;
LI, FP ;
STRONG, LC ;
FRAUMENI, JF ;
NELSON, CE ;
KIM, DH ;
KASSEL, J ;
GRYKA, MA ;
BISCHOFF, FZ ;
TAINSKY, MA ;
FRIEND, SH .
SCIENCE, 1990, 250 (4985) :1233-1238
[17]   REARRANGEMENT OF THE P53 GENE IN HUMAN OSTEOGENIC SARCOMAS [J].
MASUDA, H ;
MILLER, C ;
KOEFFLER, HP ;
BATTIFORA, H ;
CLINE, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7716-7719
[18]   COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION [J].
MILNER, J ;
MEDCALF, EA .
CELL, 1991, 65 (05) :765-774
[19]   REPORT OF THE COMMITTEE-ON-CHROMOSOME-CHANGES-IN-NEOPLASIA [J].
MITELMAN, F ;
KANEKO, Y ;
TRENT, JM .
CYTOGENETICS AND CELL GENETICS, 1990, 55 (1-4) :358-386
[20]  
MITSUDOMI T, 1992, ONCOGENE, V7, P171